(Q44413951)

English

5-HT2A receptor stimulation by DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens

scientific article published on May 16, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

5-HT 2A receptor stimulation by DOI, a 5-HT 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

5-HT2A receptor stimulation by DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens (English)

1 reference

10.1016/S0006-8993(03)02516-2

https://api.crossref.org/works/10.1016/S0006-8993(03)02516-2

27 December 2023

0 references

nucleus accumbens

1 reference

based on heuristic

inferred from title

author name string

Toshihide Kuroki

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Junji Ichikawa

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Herbert Y. Meltzer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12711095

27 December 2023

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

16 May 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12711095

27 December 2023

number of pages

6

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://api.elsevier.com/content/article/PII:S0006899303025162?httpAccept=text/xml

1 reference

10.1016/S0006-8993(03)02516-2

https://api.crossref.org/works/10.1016/S0006-8993(03)02516-2

27 December 2023

https://api.elsevier.com/content/article/PII:S0006899303025162?httpAccept=text/plain

1 reference

10.1016/S0006-8993(03)02516-2

https://api.crossref.org/works/10.1016/S0006-8993(03)02516-2

27 December 2023

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

972

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

216-221

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Serotonin 5-HT(2) receptor stimulation of dopamine release in the posterior but not anterior nucleus accumbens of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

R(+)-8-OH-DPAT, a selective 5-HT(1A) receptor agonist, attenuated amphetamine-induced dopamine synthesis in rat striatum, but not nucleus accumbens or medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Effects of the serotonin2A/2C receptor agonist and antagonist on phencyclidine-induced dopamine release in rat medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Effect of 3,4-Methylenedioxymethamphetamine on 3,4-Dihydroxyphenylalanine Accumulation in the Striatum and Nucleus Accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Local infusion of the serotonin antagonists ritanserin or ICS 205,930 increases in vivo dopamine release in the rat medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Ritanserin administration potentiates amphetamine-stimulated dopamine release in the rat prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

DOI-Induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors

36

1 reference

10.1016/S0006-8993(03)02516-2

https://api.crossref.org/works/10.1016/S0006-8993(03)02516-2

27 December 2023

Identifiers

10.1016/S0006-8993(03)02516-2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

release_fx2cmhwxkjhorovjg5liqblu7m

1 reference

https://api.fatcat.wiki/v0/release/fx2cmhwxkjhorovjg5liqblu7m

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44413951&oldid=2037943977"